C4 Therapeutics, Inc. · NASDAQ:CCCC
Wasatch Advisors LP reported a 10.50% stake in C4 Therapeutics, Inc. (Schedule 13G/A)
Event Apr 30, 2025 · Filed May 7, 2025
Wasatch Advisors LP reported a 10.50% stake in C4 Therapeutics, Inc., 7,473,332 shares, as a passive investor on Apr 30, 2025. Filed May 7, 2025 (Schedule 13G/A).
- Stake
- 10.50%
- Shares
- 7,473,332
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| WASATCH ADVISORS LP | 10.50% | 7,473,332 |
Source
Related
- C4 Therapeutics, Inc.
- Wasatch Advisors LP
- C4 Therapeutics, Inc. shareholders
- Schedule 13G/A · Wasatch Advisors LP · Apr 22, 2026
- Schedule 13G/A · Wasatch Advisors LP · Nov 13, 2025
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026